BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32013033)

  • 1. EVI1 as a Marker for Lymph Node Metastasis in HNSCC.
    Idel C; Ribbat-Idel J; Kuppler P; Krupar R; Offermann A; Vogel W; Rades D; Kirfel J; Wollenberg B; Perner S
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
    Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
    Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
    Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma.
    Scherpelz KP; Wong AC; Lingen MW; Taxy JB; Cipriani NA
    Histopathology; 2019 Jan; 74(2):321-331. PubMed ID: 30144145
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Grandits AM; Bromberger S; Heller G; Reinoehl BA; Tomasich E; Schossleitner K; Berghoff AS; Fuereder T; Wieser R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Markers Predicting Clinically Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
    Gaudioso P; Borsetto D; Polesel J; Tirelli G; Emanuelli E; Menegaldo A; Molteni G; Nicolai P; Tomasoni M; Montenegro C; Piazza C; Bossi P; Ciorba A; Canzi P; Giacomarra V; Giudici F; Fussey J; Boscolo-Rizzo P
    ORL J Otorhinolaryngol Relat Spec; 2024; 86(1):32-40. PubMed ID: 37972574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.
    Schneider S; Kadletz L; Wiebringhaus R; Kenner L; Selzer E; Füreder T; Rajky O; Berghoff AS; Preusser M; Heiduschka G
    Histopathology; 2018 Oct; 73(4):573-584. PubMed ID: 29742291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.
    Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ
    Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
    Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
    Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially expressed proteins in positive versus negative HNSCC lymph nodes.
    Vidotto A; Polachini GM; de Paula-Silva M; Oliani SM; Henrique T; López RVM; Cury PM; Nunes FD; Góis-Filho JF; de Carvalho MB; Leopoldino AM; Tajara EH
    BMC Med Genomics; 2018 Aug; 11(1):73. PubMed ID: 30157864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
    Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
    Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of occult lymph node metastasis in squamous cell carcinoma of the oral cavity and the oropharynx using peritumoral Prospero homeobox protein 1 lymphatic nuclear quantification.
    Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y
    Head Neck; 2016 Sep; 38(9):1407-15. PubMed ID: 27043718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients.
    Kühn JP; Bochen F; Körner S; Schick B; Wagner M; Smola S; Berkó-Göttel B; Morris LGT; Wang J; Bozzato A; Linxweiler M
    Int J Biol Markers; 2022 Sep; 37(3):280-288. PubMed ID: 35880270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eps8 expression is significantly lower in p16
    Nasri E; Wiesen LB; Knapik JA; Fredenburg KM
    Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study.
    Karpathiou G; Stachowitz ML; Dumollard JM; Gavid M; Froudarakis M; Prades JM; Peoc'h M
    Cancer Genomics Proteomics; 2019; 16(3):155-161. PubMed ID: 31018946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis.
    Zhang C; Qiao H; Guo W; Liu Y; Yang L; Liu Y; Jin B; Fu M; Wang G; Li W
    Cancer Lett; 2019 Jul; 455():1-13. PubMed ID: 30981760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.